Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-042194
Filing Date
2021-02-16
Accepted
2021-02-12 21:30:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d132203dsc13g.htm SC 13G 36854
  Complete submission text file 0001193125-21-042194.txt   38183
Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics Inc. (Subject) CIK: 0001650648 (see all company filings)

EIN.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91921 | Film No.: 21631566
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 19 RIMA COURT DANVILLE CA 94526
Business Address
SCHAFFER DAVID (Filed by) CIK: 0001692929 (see all company filings)

Type: SC 13G